Dr. Reddys Laboratories Ltd.
BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1244.20
9.60 (0.78%) Dr. Reddy’s Laboratories informs about press release
Date: 27-02-2023Dr. Reddy’s Laboratories has informed that it enclosed a Press Release on ‘Dr. Reddy's Laboratories announces agreement to acquire Mayne Pharma’s U.S. generic prescription product portfolio’.
The above information is a part of company’s filings submitted to BSE.